Kieffer Tara L, Kwon Patty, Nettles Richard E, Han Yefei, Ray Stuart C, Siliciano Robert F
Department of Medicine, Johns Hopkins University School of Medicine, 879 Broadway Research Bldg., 733 N. Broadway, Baltimore, MD 21205, USA.
J Virol. 2005 Feb;79(3):1975-80. doi: 10.1128/JVI.79.3.1975-1980.2005.
In vitro studies have shown that the host cytidine deaminase APOBEC3G causes lethal hypermutation in human immunodeficiency virus type 1 reverse transcripts unless its incorporation into virions is blocked by Vif. By examining stably archived sequences in resting CD4+ T cells, we show that hypermutation occurs in most if not all infected individuals. Hypermutated sequences comprised >9% of archived species in resting CD4+ T cells but were not found in plasma virus. Mutations occurred in predicted contexts, with notable hotspots. Thus, defects in Vif function in vivo give rise to hypermutated viral genomes that can be integrated but do not produce progeny viruses.
体外研究表明,宿主胞苷脱氨酶APOBEC3G会导致1型人类免疫缺陷病毒逆转录产物发生致死性超突变,除非其掺入病毒体的过程被Vif阻断。通过检查静息CD4+ T细胞中稳定存档的序列,我们发现,在大多数(如果不是全部)受感染个体中都会发生超突变。超突变序列在静息CD4+ T细胞的存档病毒种类中占比超过9%,但在血浆病毒中未发现。突变发生在预测的背景下,有明显的热点。因此,体内Vif功能缺陷会产生可整合但不产生子代病毒的超突变病毒基因组。